AYTU BIOPHARMA, INC. Cash Flow Charts

2 years of history · ending 2025-06-30 · SEC EDGAR

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Net Debt Issuance

Cash Flow

Cash Flow by Activity

Operating Cash Flow
$-2M
Free Cash Flow
$-2M
Investing Cash Flow
$-3M
Financing Cash Flow
$15M
Capex
$228K
Stock-Based Comp
$576K
Debt Issued
$2M
Debt Repaid
$2M
D&A
$200K
SBC Allocated Expense
$576K
SBC Unrecognized Cost